Loren E. Hernandez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Loren E. Hernandez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Arvin Jadoo
University of Miami Miller School of Medicine Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida, USA
1 shared publicationBrian Morrison
University of Miami Miller School of Medicine Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida, USA
1 shared publicationKeyvan Nouri
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, USA
1 shared publicationLawrence A. Schachner
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami Florida USA
1 shared publicationSamantha Verling
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, USA
1 shared publication
Latest Publications
- 17 March 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (2) , 374-375
Comment on “Evaluation of a paraffin‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial”
- 17 March 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (2) , 374-375
Comment on “Evaluation of a paraffin‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial”
- 18 August 2023
- Published by S. Karger AG in Skin Appendage Disorders
- Vol. 9 (6) , 457-460
Recurrent Fluconazole-Induced Fixed Drug Eruption of the Digit with Nail Matrix Involvement: A Case Report and Review of the Literature
Introduction: Fixed drug eruptions (FDEs) are cutaneous hypersensitivity reactions due to an offending drug and are rarely associated with nail involvement. Moreover, FDEs associated with fluconazole use are sparsely reported in literature. Case Presentation: We report a case of a recurrent FDE with involvement of one finger and corresponding Beau’s lines due to fluconazole use. The diagnosis of FDE secondary to fluconazole use was confirmed histopathologically, with improvement after the application of twice daily 0.05% clobetasol propionate ointment. Conclusion: FDEs are hypersensitivity reactions that occur after exposure to an offending drug. FDEs uncommonly affect the nail matrix and are often not caused by fluconazole. It is important for dermatologists to assess for changes in the nail plate when evaluating a patient with FDE and evaluate all medications a patient is taking.
- 18 August 2023
- Published by S. Karger AG in Skin Appendage Disorders
- Vol. 9 (6) , 457-460
Recurrent Fluconazole-Induced Fixed Drug Eruption of the Digit with Nail Matrix Involvement: A Case Report and Review of the Literature
Introduction: Fixed drug eruptions (FDEs) are cutaneous hypersensitivity reactions due to an offending drug and are rarely associated with nail involvement. Moreover, FDEs associated with fluconazole use are sparsely reported in literature. Case Presentation: We report a case of a recurrent FDE with involvement of one finger and corresponding Beau’s lines due to fluconazole use. The diagnosis of FDE secondary to fluconazole use was confirmed histopathologically, with improvement after the application of twice daily 0.05% clobetasol propionate ointment. Conclusion: FDEs are hypersensitivity reactions that occur after exposure to an offending drug. FDEs uncommonly affect the nail matrix and are often not caused by fluconazole. It is important for dermatologists to assess for changes in the nail plate when evaluating a patient with FDE and evaluate all medications a patient is taking.
- 24 July 2023
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 315 (9) , 2735-2736
Lack of diversity in vitiligo clinical trials: a cross-sectional analysis
- 24 July 2023
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 315 (9) , 2735-2736
Lack of diversity in vitiligo clinical trials: a cross-sectional analysis